Understanding Clinical Trials
Every therapy, drug or approach that is in place today to treat cancer had its start in a clinical trial. At Hope Cancer Care of Nevada, we provide access to innovative treatment options through clinical trials with the Nevada Cancer Research Foundation, a National Cancer Institute Community Oncology Research Program (NCORP).
Click here for a list of available trials.
Why Participate in Clinical Trials?
Clinical trials are designed to evaluate the effectiveness of new treatment interventions. The objective of these clinical trials is to test new therapies in patients who have cancer. Patients participate in clinical trials for several reasons, including:
- The potential to benefit from a new drug or treatment procedure
- Improved management of symptoms resulting from treatment of cancer
- The opportunity to directly contribute to improving the understanding of how to treat a cancer and ultimately, benefit other patients
Patients who participate in clinical trials receive either a promising new treatment or the best available conventional treatment. If a new treatment option is proven to work, patients who are participating in the clinical trial will be among the first to benefit. While there is no guarantee that any treatment will be successful, clinical trials have been proven to offer some of the most effective cancer treatments currently available today.
Talk to your doctor to discuss your clinical trial options.
NCI study shows feasibility of cancer screening protocol for patients with Li-Fraumeni syndrome
A new NCI study demonstrates the feasibility of a comprehensive screening protocol for patients with Li-Fraumeni syndrome, a rare inherited disorder that leads to a higher risk of developing certain cancers. …read more Source:: Cancer
NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers
The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations. …read more Source:: Cancer
Ventilated Filters: Changing the Face of Lung Cancer in the U.S.
By David Sampson An analysis appearing in the Journal of the National Cancer Institute finds strong evidence that adding ventilation holes to cigarette filters has contributed to a rise in a type of lung cancer called adenocarcinoma among smokers. The … Read More
Study estimates number of U.S. women living with metastatic breast cancer
A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population … Read More
14: The Unmentioned Number in the Prostate Cancer/Coffee Story
By David Sampson Headlines across the Internet blared with the news over the past week that coffee could cut the risk of prostate cancer in half. It was an irresistible headline. But just how reliable was the finding? What if … Read More
Panel Re-Opens the Door for PSA Screening in Men 55-69
By David Sampson The U.S. Preventive Services Task Force (USPSTF) has released draft recommendations for the use of prostate-specific antigen (PSA) screening for prostate cancer. The recommendation, which awaits public comment before being finalized, says the decision about whether to … Read More
Annual Report to the Nation: Cancer death rates continue to decline
According to the latest Annual Report to the Nation on the Status of Cancer, 1975-2014, overall cancer death rates continue to decrease in men, women, and children for all major racial and ethnic groups. But more work remains for some … Read More
ACS Study: Finds Colorectal Cancer Rates Have Risen Dramatically in Gen X and Millennials
By David Sampson A groundbreaking study by American Cancer Society epidemiologist Rebecca Siegel, MPH finds that people born in the United States in 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer compared to … Read More
NCI launches study of African-American cancer survivors
The Detroit Research on Cancer Survivors (ROCS) study, which will include 5,560 cancer survivors, will look at the major factors affecting cancer progression, recurrence, mortality, and quality of life among African-American cancer survivors. …read more Source:: Cancer
Study finds premature death rates diverge in the United States by race and ethnicity
Premature death rates declined among Hispanics, blacks, and Asian/Pacific Islanders due mainly to fewer deaths from cancer, heart disease, and HIV. Rising deaths from accidents, drug overdoses, suicide and liver disease increased rates among whites and American Indian/Alaska Natives. …read … Read More
